Biofrontera (BFRI) Total Non-Current Liabilities (2020 - 2026)
Biofrontera (BFRI) recorded Total Non-Current Liabilities of $17.58 million in Q2 2026, down 27.5% from $24.26 million a year earlier.
Biofrontera (BFRI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Biofrontera reported Total Non-Current Liabilities of $17.73 million, up 8.0% from FY2024.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $16.42 million in FY2024 (-13.3%), $18.93 million in FY2023 (-21.7%), $24.16 million in FY2022 (-16.8%) and $29.03 million in FY2021 (+59.1%).
- Quarterly Total Non-Current Liabilities has ranged from $9.74 million in Q2 2024 to $29.03 million in Q4 2021 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities rose in three of the last seven quarters, with growth averaging 14.3%.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 149.0% in Q2 2025, against a decline of 51.3% in Q3 2024 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Biofrontera | 10.34 Mn | -11.45 Mn | 9.59 Mn | 17.57 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.57 Mn |
| Dec 31, 2025 | 17.72 Mn |
| Sep 30, 2025 | 17.15 Mn |
| Jun 30, 2025 | 24.25 Mn |
| Mar 31, 2025 | 15.40 Mn |
| Dec 31, 2024 | 16.40 Mn |
| Sep 30, 2024 | 11.36 Mn |
| Jun 30, 2024 | 9.71 Mn |
| Mar 31, 2024 | 18.23 Mn |
| Dec 31, 2023 | 18.89 Mn |
| Sep 30, 2023 | 19.98 Mn |
| Mar 31, 2023 | 11.94 Mn |
| Dec 31, 2022 | 21.74 Mn |
| Sep 30, 2022 | 8.19 Mn |
| Jun 30, 2022 | 22.70 Mn |
| Mar 31, 2022 | 21.99 Mn |
| Dec 31, 2021 | 1.05 Mn |
| Sep 30, 2021 | 17.76 Mn |
| Dec 31, 2020 | 18.25 Mn |
Biofrontera Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BFRI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "BFRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BFRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();